Feasibility Study of a Novel Stent‐Based Low‐Level Laser Therapy Device for Reducing Severe Radiation‐Induced Oral Mucositis
Lasers in Surgery and Medicine · 2025
DOI: 10.1002/lsm.70069 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Lasers in Surgery and Medicine, 2025. Verfasst von Jong Yun Baek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Stomatitis, Low-Level Light Therapy, Stents, Head and Neck Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objectives
Radiation‐induced oral mucositis (RIOM) is a severe complication of radiotherapy (RT) for head and neck cancers, impairing quality of life and treatment adherence. Low‐level laser therapy (LLLT) shows promise for reducing RIOM severity, but operator‐dependent devices limit practicality. This feasibility study assessed the safety and efficacy of a novel intraoral stent‐based LLLT device designed for consistent laser delivery. Materials and Methods This prospective, single‐arm, multicenter study enrolled 15 patients receiving curative RT for head and neck cancers. The stent‐based device delivered laser light to 43 oral cavity points at three wavelengths (670, 830, and 910 nm) during 20‐min sessions, five times weekly. The primary end point was the incidence of Grade 3 or higher RIOM (WHO oral mucositis scale). Pain severity was a secondary end point (Numeric Pain Rating Scale [NPRS]).
Results
Grade 3 or higher RIOM occurred in 6.6% of patients, significantly lower than historical rates (30%–40%). No patients reported severe pain (NPRS ≥ 8). The device was well‐tolerated with no adverse effects, and all patients completed RT as planned.
Conclusions
The intraoral stent‐based LLLT device is a safe and potentially effective intervention for reducing severe RIOM. Randomized trials are warranted to confirm these findings. Trial Registration This study was a prospective, single‐arm feasibility trial and was not registered in a clinical trial registry, as it did not meet the criteria for mandatory registration at the time of its initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang-si, South Korea.
- Department of Radiation Oncology, Soonchunhyang University Hospital, Cheonan, South Korea.
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
ORCID-Profile: Kyungmi Yang, Tae Hoon Lee, Dongryul Oh
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Baek, J. Y., Yang, K., Lee, T. H., Lee, S. U., Moon, S. H., Jo, I. Y., Eom, K. Y., & Oh, D. (2025). Feasibility Study of a Novel Stent‐Based Low‐Level Laser Therapy Device for Reducing Severe Radiation‐Induced Oral Mucositis. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.70069
Vancouver
Baek JY, Yang K, Lee TH, Lee SU, Moon SH, Jo IY, et al. Feasibility Study of a Novel Stent‐Based Low‐Level Laser Therapy Device for Reducing Severe Radiation‐Induced Oral Mucositis. Lasers in Surgery and Medicine. 2025. doi:10.1002/lsm.70069
BibTeX
@article{Baek2025,
author = {Baek, Jong Yun and Yang, Kyungmi and Lee, Tae Hoon and Lee, Sung Uk and Moon, Sung Ho and Jo, In Young and Eom, Keun-Yong and Oh, Dongryul},
title = {Feasibility Study of a Novel Stent‐Based Low‐Level Laser Therapy Device for Reducing Severe Radiation‐Induced Oral Mucositis},
journal = {Lasers in Surgery and Medicine},
year = {2025},
doi = {10.1002/lsm.70069}
}
EUVIMED